The EU-funded infrastructure enables the discovery of new natural compounds, helps to understand microbial ecosystems and their role in health and disease, and allows the development of targeted therapies. “Our scientists are working on new therapies against infectious diseases, which are invaluable, especially in times of global health crises such as new pathogens or increasing antibiotic resistance. In addition, our research makes a significant contribution to the regional economy by promoting innovation, supporting start-ups and creating highly qualified personnel for Thuringia's high-tech industry. Investing in this value chain pays off in the long term for the federal and state governments,” says Institute Director Axel Brakhage. With its numerous research funding programs, the European Union is not only strengthening the Leibniz-HKI, but also cutting-edge research throughout Thuringia.